| Session 1. Enhancing Competitiveness in Multinational Clinical Trials |
|
As the pharmaceutical market becomes globalized, more countries from around the world are participating in clinical trials. While previous trials were confined to Europe and North America, Asia has become an important player in international trials. Not only does Asia have good science and relative low costs, but also the potential to grow into one of the largest pharmaceutical markets. Although India and China are strong competitors, Korea is fast growing to become a clinical trial hub. In this session, a overview of the drug development process will be provided with considerations on how Korea should enhance its competitiveness. |
Chair : Dong Ho LEE, Professor, Asan Medical Center |
 |
| - Modern Drug Discovery : Dengue |
| Paul L. HERRLING, Professor/Head, Corporate Research, Novartis International AG |
|
   |
|
| - Enhancing Competitiveness in Multinational Clinical Trials |
| So-Ra LEE, Head of Clinical Operations, Medical Dept., Pfizer Pharmaceutical Korea Ltd. |
|
 |
|
- Shortening the Gap on Attaining the Computerized Clinical System
Validation Environment |
| Kyungsub CHOI, Assistant Professor, Computer Information Systems, Manhattan College |
|
 |
|
|
| Session 2. Clinical Trial Expert Education and Training Ⅰ |
|
Clinical trials require the professionality from multi-disciplinaries; investigators, statisticians and industries always endeavour in developing protocols, coordinating trials and managing data. In this session, various aspects of clinical trials will be provided by professionals with different parts in this area. Each speaker will talk about the roles and responsibilities of their profession; and also discuss about the shortage of professionals and the methods in educating them. |
| Chair : Jae Gook SHIN, Professor/Director , College of Medicine, Inje Univ. & Pharmacogenomics Reasearch Center |
|
| - Clinical Investigator Education and Training Program |
| Young Kyoon KIM, Professor, Dept. of Internal Medicine, Division of Pulmonary and Critical Medicine, Kangnam St. Mary's Hospital, The Catholic Univ. of Korea |
|
|
|
- Education and Training Program for Experts in Pharmaceutical
Medicine |
| Hye-Young KANG, Associate Professor, Graduate School of Public Health, Yonsei Univ. |
|
|
|
| - Statistical Issues for Design of Clinical Trials |
| Seokyung HAHN, Assistant Professor, College of Medicine, Seoul Nat’l Univ. |
|
 |
|
|
| Session 3. Clinical Trial Expert Education and Training II |
|
Recently, Korea has witnessed a remarkable increase in clinical trials; but also a demanding need for more professionals. As many education programs have emerged during the past few years, there is a growing need for certifying each program. Clinical trial professionals, including clinical pharmacologists, pharmacists and clinical research associates (CRAs) will talk about systems required to educate qualified experts. |
Chair : Min Soo Park, Professor, College of Medicine, Yonsei Univ. |
|
| - Training Clinical Pharmacologists |
| Kyung-Sang YU, Assistant Professor, Dept. of Clinical Pharmacology & Therapeutics, Clinical Trials Center, Seoul Nat'l Univ. & Hospital |
|
|
|
| - CRA Education and Training Program |
| JaeYong SHIM, Associate Professor, College of Medicine, Yonsei Univ. |
|
|
|
- Training Program for Clinical Research Pharmacist
: Focused on Education Course for Clinical Trial Pharmacists
Designated by KoNECT (Korea National Enterprise for Clinical Trials) |
| Ok-Youn HAN, Pharmacy Director, The Catholic Univ. of Korea, Kangnam St.Mary's Hospital |
|
|
|
|
|
